Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

Mayne Pharma Group Limited

INVESTOR PRESENTATION - Mayne Pharma Group Limited

ASX:MYX

Mayne Pharma Group Limited

Health

Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, NC, USA. Former Names Halcygen Pharmaceuticals Limited (HGN), 18/11/2010

Read more

Market Cap

$596.07m

Price at Close

$0.355

4w avg. Volume

996.66k

4w avg. Turnover

$350.97k

Announcements
announcementt+2 movementdate
  • Mayne Pharma launches Microgestin 24 FE tablets in the US

    Progress Report

  • +1.43%

    06 Jan 2021

+1.43%

06 Jan 2021
  • Mayne Pharma successfully extends debt facility

    Periodic Reports

  • 0.00%

    17 Dec 2020

0.00%

17 Dec 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • +2.78%

    04 Dec 2020

+2.78%

04 Dec 2020
  • Appendix 3G

    Issued Capital

  • +2.78%

    04 Dec 2020

+2.78%

04 Dec 2020
  • 2020 AGM Results

    Notice Of Meeting

  • +1.41%

    24 Nov 2020

+1.41%

24 Nov 2020
  • Chairman and CEO's Addresses to Shareholders

    Periodic Reports · Market sensitive

  • 0.00%

    23 Nov 2020

0.00%

23 Nov 2020
  • Mayne Pharma Board Renewal

    Company Administration

  • -1.54%

    09 Nov 2020

-1.54%

09 Nov 2020
  • New data on Mayne Pharma's TOLSURA presented at IDWeek 2020

    Progress Report

  • -3.13%

    25 Oct 2020

-3.13%

25 Oct 2020
  • Lapse of rights and AGM Notice of Meeting clarification

    Issued Capital

  • -3.08%

    23 Oct 2020

-3.08%

23 Oct 2020
  • Becoming a substantial holder

    Shareholder Details

  • +3.13%

    14 Oct 2020

+3.13%

14 Oct 2020
Market Data

Current Price

$0.355

52WK HIGH

$0.485

52WK LOW

$0.195

1YR RETURN

-26.80%

1YR RETURN VS. SECTOR

-63.63%

90 DAY RETURN

+10.94%

ASX RANK

357

/2,047

SECTOR RANK

21

/168

SHARES OUTSTANDING

1.68b
ASX:MYX

Mayne Pharma Group Limited

Health

Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, NC, USA. Former Names Halcygen Pharmaceuticals Limited (HGN), 18/11/2010

Read more

Market Cap

$596.07m

Price at Close

$0.355

4w avg. Volume

996.66k

4w avg. Turnover

$350.97k

ASX:MYX is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.